
Breast Implants Linked to Rare Cancer Are Recalled Worldwide
Under pressure from the Food and Drug Administration, Allergan will stop selling textured implants. Thirty-three deaths have been tied to the devices.
By
Advertisement
Supported by

Under pressure from the Food and Drug Administration, Allergan will stop selling textured implants. Thirty-three deaths have been tied to the devices.
By

Computer scientists have developed an algorithm that can pick out almost any American in databases supposedly stripped of personal information.
By

In preliminary tests, a matchstick-size rod containing a new drug offered promise as a shield against the virus. But a large clinical trial must still be done.
By

“Something happened to the brain” of diplomats who reported odd ailments, brain-imaging study suggests. But the cause is still unclear.
By

An expert called the laws in both Utah and Oregon a “win” and said students who are “quietly suffering” from mental illness will benefit most.
By

In animals, weight training appeared to promote the creation of new neurons in the memory centers of the brain.
By

Even when older plaintiffs win their suits, correcting institutional biases can take years.
By

Those with the least understanding of science oppose it the most and also think they know the most, a study showed.
By

The company, Hubble, offers customers contact lens subscriptions at low monthly prices. Critics say it bypasses eye care professionals, doesn’t properly vet prescriptions and takes advantage of federal regulations to the detriment of consumers.
By
Advertisement

Overuse of antibiotics in livestock has given rise to drug-resistant germs. Drugmakers say they want to be part of the solution. But a recent campaign urged farmers to administer the drugs to healthy animals daily.
By Danny Hakim and

The state health department calls on hospitals to do more to fight Candida auris, a mystery germ spreading the globe.
By

In its decision to approve two drugs for orange and grapefruit trees, the E.P.A. largely ignored objections from the C.D.C. and the F.D.A., which fear that expanding their use in cash crops could fuel antibiotic resistance in humans.
By Andrew Jacobs and

A new report says the overuse of antimicrobial drugs in humans, animals and plants is fueling resistant pathogens that could kill 10 million people annually by 2050.
By

The mysterious infection has appeared at hospitals around the world, but few institutions or families have discussed their experience.
By
Advertisement
Advertisement